Darien Parhad serves as Chief Financial Officer at Paragon Biosciences. He is responsible for financial accounting and reporting, budgeting, tax and treasury management.

Mr. Parhad brings 20 years of financial expertise to his role at Paragon. Previously, he was a Controller at Marathon Pharmaceuticals and Lundbeck, as well as Director of Accounting at Ovation Pharmaceuticals. He began his career at Deloitte & Touche, working in roles of rapidly increasing responsibility.

Mr. Parhad is a Certified Public Accountant and a graduate of DePaul University with a bachelor’s degree in accountancy.